What should be done if opioid therapy risks outweigh benefits, according to the CDC guidelines?

When opioid therapy presents more risks than benefits, CDC guidelines recommend working with the patient to taper the opioids. This approach is correct as it recognizes the necessity of reducing the potential for dependence, withdrawal, and adverse effects while considering the patient's pain management needs. Tapering allows for a gradual decrease in dosage, which can help minimize withdrawal symptoms and allow for a more controlled transition to alternative pain management strategies.

Providing a tapering schedule also supports the patient's engagement in their treatment plan, promoting better adherence and understanding of their therapy. This approach acknowledges the complexities of opioid therapy and the importance of addressing both the physical and psychological aspects of opioid use.

In contrast, continuing the same dosage would not address the concerns surrounding risks and would perpetuate potential harm. Discontinuing therapy immediately without tapering could lead to severe withdrawal symptoms and is generally not recommended as it can result in significant distress for the patient. Increasing the dosage cautiously could further amplify the risks associated with opioid therapy rather than mitigating them.